Sabato 23 Febbraio 2019

Ricerche Pubblicazioni


Le ricerche sono disponibili nelle seguenti riviste internazionali.
The researches are available in the following international reviews.

  • Acta Haematologica
  • AIDS 
  • AIDS Res. Human Retrov.
  • Allergology and Immunopathol.
  • Allergy
  • Am. J. Epidemiology
  • Amer. J. Med. Genetic
  • Amer. N.Y. Acad. Science
  • Ann. Allergy
  • Antiviral Res.
  • Biol.Blood Marrow Transplant
  • Birth Defect Orig. Series Art.
  • Blood
  • British J. Haematology
  • British Med. Journal
  • Clin. Exp. Allergy
  • Clin. Exp. Immunol.
  • Contact Dermatitis
  • Eur. Int. J. Allergy
  • Eur. J. Immunology
  • Eur. J. Cancer
  • Eur. J. Epidem.
  • Eur. J. Ophtalmology
  • Gut
  • Haematologica
  • Human Immunol.
  • Human Reproduction
  • Immunodeficiency
  • Immunology
  • Immunology Today
  • Infection
  • Infection Immunology
  • Inter. Arch. Allergy Appl. Immunol.
  • Inter. J. Immmunopharmacol.
  • J. Immunodeficiency
  • J. of Immunology
  • J. Immunol. Immunopathol.
  • J. Allergy
  • J. Allergy Clin. Immunol.
  • J. Clin. Immunol.
  • J. Clin. Microb.
  • J. Exp. Med.
  • J. Infectious Diseases
  • J. Natl. Cancer Inst.
  • J. of AIDS
  • J. Perinatal Medicine
  • J. Psycosomatic Research
  • Lancet
  • Monograft in Allergy
  • Nature
  • New England J. Medicine
  • Pediatric
  • Pediatric Research
  • Pharmacol Research
  • Review in Immunology
  • Scand.J. Immunol.
  • Science
  • Thymus
  • Tranplantation Proc.
  • Transfusion
  • Tumori
  • Vaccine
  • Viral Immunology
  • Vox Sanguinis
  • Zeitsch. Immunitatforsch Immunobiol.


Ha pubblicato più di 600 lavori scientifici, 385 dei quali sono stati pubblicati in riviste internazionali e riportati dalla International Med Line. Le pubblicazioni che vanno dal 1964 al 2011 sono disponibili su Internet ricercando la International Med Line.

He has published more then 600 papers and 385 have been published in international journals and reported by the International Med Line. The publications for the period from 1964 to 2011 are available in the International Med Line.

Pubblicazioni significative negli ultimi 6 anni.
Significant Publications in the last 6 years.

  1. Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT). Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, Gordin F, Angus B, Rodriguez M, Rubio R, Tambussi G, Cooper DA, Aiuti F. in INSIGHT-ESPRIT Study Group. HIV Med. 2011 Apr;12(4):269-281.
  2. Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia.Isgrò A, Marziali M, Sodani P, Gaziev J, Erer B, Polchi P, Paciaroni K, Roveda A, De Angelis G, , Lanti A, Leti W, Aiuti F. Biol Blood Marrow Transplant. 2010 Nov;16(11):1557-66.
  3. Undifferentiated connective tissue disease - an unsolved problem:revision of literature and case studies. Conti V, Esposito A, Cagliuso M, Fantauzzi A, Pastori D, Mezzaroma I, Aiuti F. Int J Immunopathol Pharmacol. 2010 Jan-Mar;23(1):271-278
  4. Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials. Steigbigel RT, Cooper DA, Teppler H, Eron JJ, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Katlama C, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Barnard RJ, Isaacs RD, Nguyen BY; Aiuti F .in BENCHMRK Study Team. Clin Infect Dis. 2010 Feb 15;50(4):605-12.
  5. Immunorecovery after prolonged HIV-related immunosuppression: opportunities of the new antiretroviral classes.Esposito A, Leti W, Fantauzzi A, Pastori D, Isgro A, Aiuti F. Mezzaroma I. Infez Med. 2009 Sep;17(3):178-83.
  6. Interleukin-2 therapy in patients with HIV infection. INSIGHT-ESPRIT Study Group; SILCAAT Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordi e Aiuti F. et al. N Engl J Med 2009 Oct 15;361(16):1548-59.
  7. Improvement in lipid profiles in antiretroviral-experienced HIV-positive patients with hyperlipidemia after a switch to unboosted atazanavir.Sension M, Andrade Neto JL, Grinsztejn B, Molina JM, Zavala I, González-García J, Donnelly A, Phiri P, Ledesma E, McGrath D; and Aiuti F .in Study Group. J Acquir Immune Defic. Syndr. 2009 Jun 1;51(2):153-62.
  8. Unsung hero Robert C. Gallo. Abbadessa G, Accolla R, Aiuti F. et al. Science. 2009 Jan 9;323(5911):206-7.
  9. Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. Fätkenheuer G, Nelson M, Lazzarin A, MOTIVATE 1 and MOTIVATE 2 Study Teams . Aiuti F. et al. N Engl J Med. 2008 Oct 2;359(14):1442-55.
  10. Maraviroc for previously treated patients with R5 HIV-1 infection.Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H. Aiuti F. et. al. MOTIVATE Study Teams N Engl J Med. 2008 Oct 2;359(14):1429-41.
  11. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.Saracino A, Gianotti N, Marangi M, Cibelli DC, Galli A, Punzi G, Monno L, Lazzarin A., Angarano G. Aiuti et al. al. Mutations, Salvage Study Group: J Med Virol. 2008 Oct;80(10):1695-706.
  12. Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.Cooper DA, Steigbigel RT, Gatell JM, Rockstroh JK, Katlama C, Yeni P, Lazzarin A, AR, Miller MD, Hazuda DJ, Nessly ML, DiNubile MJ, Isaacs RD, Teppler H, Nguyen BY; :Aiuti F. et al. BENCHMRK Study T.N. Engl. J. Med. 2008 Ju24;359(4):355-65.
  13. Raltegravir with optimized background therapy for resistant HIV-1 infection.Steigbigel RT, Cooper DA, Kumar PN, Eron JE, Schechter M, Markowitz M, Loutfy H,Aiuti et al. BENCHMRK Study Teams. N Engl J Med. 2008 Jul 24;359(4):339-54.
  14. T-cell homeostasis: the darkened side of common variable immunodeficiency.Giovannetti A, Pierdominici M, Aiuti F. Blood. 2008 Jul 15;112(2):446; 446-7.
  15. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART. Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, Luzi G, Pinti M, Cossarizza A, Aiuti F., Mezzaroma I. Clin Infect Dis. 2008 Jun 15;46(12):1902-10.
  16. Progressive derangement of the T cell compartment in a case of Evans syndrome.Giovannetti A, Pierdominici M, Esposito A, Cagliuso M, Stifano G, Giammarioli AM, Maselli A, Malorni W, Salsano F, Aiuti F.Int Arch Allergy Immunol. 2008;145(3):258-67. Epub 2007 Oct 5.
  17. Functional interleukin-7/interleukin-7Ralpha, and SDF-1alpha/CXCR4 are expressed by human periodontal ligament derived mesenchymal stem cells.Trubiani O, Isgro A, Zini N, Antonucci I, Aiuti F, Di Primio R, Nanci A, Caputi S, Paganelli R. J Cell Physiol. 2008 Mar;214(3):706-13.
  18. The 2005 Italian Quality Control Study for the evaluation of CD4 cells in centers involved in the treatment of HIV type 1 patients.Martini F, D'Offizi G, Girardi E, Vitale A, Cimini E, Mollicone B, Vlassi C, Aiuti F. and other Members of 2005 Italian CD4 Quality Control Network.AIDS Res Hum Retroviruses. 2007 Jun;23(6):777-81

Pubblicazioni significative negli ultimi 17 anni.
Significant publications in the last 17 years.

  1. Antonello Giovannetti, Marina Pierdominici, Francesca Mazzetta, Marco Marziali, Cristina Renzi, Marco De Felice, Anna Maria Mileo, Barbara Mora, Antonella Esposito, Antonio Pizzuti, Marco G. Paggi, Roberto Paganelli, Walter Malorni, and Fernando Aiuti Unravelling the Complexity of T cell Abnormalities in Common Variable Immunodeficiency J. Immunology. 2007, 178(6) 2932-43
  2. Ahuja SK, Aiuti F, Berkhout B, Biberfeld P, Burton DR, Colizzi V, Deeks SG, Desrosiers RC, Dierich MP, Doms RW, Emerman M, Gallo RC, Girard M, Greene WC, Hoxie JA, Hunter E, Klein G, Korber B, Kuritzkes DR, Lederman MM, Malim MH, Marx PA, McCune JM, McMichael A, Miller C, Miller V, Montagnier L, Montefiori DC, Moore JP, Nixon DF, Overbaugh J, Pauza CD, Richman DD, Saag MS, Sattentau Q, Schooley RT, Shattock R, Shaw GM, Stevenson M, Trkola A, Wainberg MA, Weiss RA, Wolinsky S, Zack JA. A plea for justice for jailed medical workers. Science. 2006 Nov 10;314(5801):924-5.
  3. Marziali M, De Santis W, Carello R, Leti W, Esposito A, Isgro A, Fimiani C, Sirianni MC, Mezzaroma I, Aiuti F. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART. AIDS. 2006 Oct 24;20(16):2033-41.
  4. Aiuti F, Mezzaroma I. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. AIDS Rev. 2006 Apr-Jun;8(2):88-97. Review.
  5. De Santis W, Esposito A, Conti V, Fantauzzi A, Guerra A, Mezzaroma I, Aiuti F.Health care and infective aspects in patients affected by Common Variable Immunodeficiency assisted in the Lazio Regional Authority Reference Centre for Primary Immunodeficiencies.Infez Med. 2006 Mar;14(1):13-23.
  6. Sirianni MC, Atzori C, De Santis W, Milito C, Esposito A, Marziali M, Bernardi ML, Cargnel A, Aiuti F. A case of Pneumocystis jiroveci pneumonia in X-linked agammaglobulinaemia treated with immunosuppressive therapy: a lesson for immunologists.Int Arch Allergy Immunol. 2006;140(1):82-8.
  7. Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, Silva de Mendonca J, Falleiros Carvalho LH, Panos G, Pinchera A, Aiuti F, Lee C, Horban A, Gatell J, Phanuphak P, Prasithsirikul W, Gazzard B, Bloch M, Danner SA. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV Med. 2006 Apr;7(3):146-55.
  8. Isgro A, Aiuti A, Leti W, Gramiccioni C, Esposito A, Mezzaroma I, Aiuti F.Immunodysregulation of HIV disease at bone marrow level. Autoimmun Rev. 2005 Nov;4(8):486-90. Review.
  9. Isgro A, Marziali M, Mezzaroma I, Luzi G, Mazzone AM, Guazzi V, Andolfi G, Cassani B, Aiuti A, Aiuti F. Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency. J Immunol. 2005 Apr 15;174(8):5074-81.
  10. Isgro A, Sirianni MC, Gramiccioni C, Mezzaroma I, Fantauzzi A, Aiuti F. Idiopathic CD4+ Lymphocytopenia May Be due to Decreased Bone Marrow Clonogenic Capability. Int Arch Allergy Immunol. 2005;136(4):379-384.
  11. Carsetti R, Rosado MM, Donnanno S, Guazzi V, Soresina A, Meini A, Plebani A, Aiuti F, Quinti I. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol. 2005 Feb;115(2):412-7.
  12. Isgro A, Aiuti A, Mezzaroma I, Ruco L, Pinti M, Cossarizza A, Aiuti F. HIV type 1 protease inhibitors enhance bone marrow progenitor cell activity in normal subjects and in HIV type 1-infected patients. AIDS Res Hum Retroviruses. 2005 Jan;21(1):51-7.
  13. Isgro A, Mezzaroma I, Aiuti A, Fantauzzi A, Pinti M, Cossarizza A, Aiuti F. Decreased apoptosis of bone marrow progenitor cells in HIV-1-infected patients during highly active antiretroviral therapy.AIDS. 2004 Jun 18;18(9):1335-7.
  14. Giovannetti A, Pierdominici M, Marziali M, Mazzetta F, Caprini E, Russo G, Bugarini R, Bernardi ML, Mezzaroma I, Aiuti F. Persistently biased T-cell receptor repertoires in HIV-1-infected combination antiretroviral therapy-treated patients despite sustained suppression of viral replication.J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):140-54.
  15. Aiuti F, Giovannetti A. Structured interruptions of therapy: looking for the best protocol. AIDS. 2003 Oct 17;17(15):2257-8.
  16. Luzi G, Zullo A, Iebba F, Rinaldi V, Sanchez Mete L, Muscaritoli M, Aiuti F. Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients. Am J Gastroenterol. 2003 Jan;98(1):118-21.
  17.  Aiuti F, Iebba F. Intestinal mucosa immunity and oral vaccines especially regarding E. coli vaccines: a review Infez Med. 2002 Dec;10(4):191-203. Review. Italian.
  18. Isgro A, Aiuti F, Mezzaroma I, Franchi F, Mazzone AM, Lebba F, Aiuti A. Interleukin 7 production by bone marrow-derived stromal cells in HIV-1-infected patients during highly active antiretroviral therapy. AIDS. 2002 Nov 8;16(16):2231-2.
  19. Quinti I, Pierdominici M, Marziali M, Giovannetti A, Donnanno S, Chapel H, Bjorkander J, Aiuti F; European Study Group for the Surveillance of Immunoglobulin Safety.  European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries.Clin Immunol. 2002 Sep;104(3):231-6.
  20. Isgro A, Aiuti A, Mezzaroma I, Addesso M, Riva E, Giovannetti A, Mazzetta F, Alario C, Mazzone A, Ruco L, Aiuti F. Improvement of interleukin 2 production, clonogenic capability and restoration of stromal cell function in human immunodeficiency virus-type-1 patients after HAART.Br J Haematol. 2002 Sep;118(3):864-74.
  21. Ensoli F, Fiorelli V, Lugaresi A, Farina D, De Cristofaro M, Collacchi B, Muratori DS, Scala E, Di Gioacchino M, Paganelli R, Aiuti F. Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. Mult Scler. 2002 Aug;8(4):284-8.
  22. Guazzi V, Aiuti F, Mezzaroma I, Mazzetta F, Andolfi G, Mortellaro A, Pierdominici M, Fantini R, Marziali M, Aiuti A. Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles.Clin Exp Immunol. 2002 Aug;129(2):346-53.
  23. Ensoli F, Fiorelli V, De Cristofaro M, Collacchi B, Santini Muratori D, Alario C, Sacco G, Iebba F, Aiuti F. Endogenous cytokine production protects T cells from spontaneous apoptosis during highly active antiretroviral therapy.HIV Med. 2002 Apr;3(2):105-17.
  24. Pierdominici M, Giovannetti A, Ensoli F, Mazzetta F, Marziali M, De Cristofaro MR, Santini-Muratori D, Leti W, Aiuti F.Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic. Syndr. 2002 Feb 1;29(2):122-31.
  25. Sirianni MC, Ensoli F, Alario C, Fiorelli V, Sacco G, Topino S, Iebba F, Mezzaroma I, Aiuti F. Distribution of the natural killer-related receptor for HLA-C during highly active antiretroviral therapy for human immunodeficiency virus infection. Hum Immunol. 2001 Dec;62(12):1328-34. Erratum in: Hum Immunol 2002 Apr;63(4):336.
  26.  Sirianni MC, Barbone B, Monarca B, Nanni M, Lagana B, Aiuti F. A case of Behcet's disease complicated by visceral Leishmaniasis and myelodysplasia: clinical considerations. Haematologica. 2001 Sep;86(9):1004-5.
  27. Muscaritoli M, Fanfarillo F, Luzi G, Sirianni MC, Iebba F, Laviano A, Russo M, Aiuti F, Rossi Fanelli F.Impaired nutritional status in common variable immunodeficiency patients correlates with reduced levels of serum IgA and of circulating CD4+ T lymphocytes. Eur J Clin Invest. 2001 Jun;31(6):544-9.
  28.  Giovannetti A, Mazzetta F, Coviello R, Casadei AM, Sartorerri MR, Marziali M, Pierdominici M, Kuonen D, Pesce AM, Fiorilli M, Aiuti F, Quinti I.T-Cell immune activation in children with vertically transmitted hepatitis C virus infection.Viral Immunol. 2001;14(2):169-79.
  29. Propato A, Schiaffella E, Vicenzi E, Francavilla V, Baloni L, Paroli M, Finocchi L, Tanigaki N, Ghezzi S, Ferrara R, Chesnut R, Livingston B, Sette A, Paganelli R, Aiuti F, Poli G, Barnaba V.Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity.Hum Immunol. 2001 Jun;62(6):561-76.
  30. Giovannetti A, Pierdominici M, Mazzetta F, Salemi S, Marziali M, Kuonen D, Iebba F, Lusi EA, Cossarizza A, Aiuti F.T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity.Clin Exp Immunol. 2001 Apr;124(1):21-31.
  31. Sirianni MC, Mattiacci G, Barbone B, Mari A, Aiuti F, Kleine-Tebbe J. Anaphylaxis after Argas reflexus bite. Allergy. 2000 Mar;55(3):303.
  32. Floridia M, Tomino C, Bucciardini R, Ricciardulli D, Fragola V, Pirillo MF, Amici R, Giannini G, Galluzzo CM, Andreotti M, Seeber AC, Ammassari A, Cingolani A, Lazzarin A, Scalise G, Cargnel A, Suter F, Milazzo F, Pastore G, Moroni M, Ciammarughi R, Pini R, Carosi G, D'Amato C, Contu L, Concia E, Bonazzi L, Aiuti F, Vigevani G, Vella S. A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.AIDS Res Hum Retroviruses. 2000 Nov 20;16(17):1809-20.
  33.  Ensoli F, Fiorelli V, De Cristofaro M, Muratori DS, Novi A, Isgro A, Aiuti F. Role of immune-derived diffusible mediators in AIDS-associated neurological disorders. Arch Immunol Ther Exp (Warsz). 2000;48(4):259-66. Review.
  34. Isgro A, Mezzaroma I, Aiuti A, De Vita L, Franchi F, Pandolfi F, Alario C, Ficara F, Riva E, Antonelli G, Aiuti F.Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy.AIDS Res Hum Retroviruses. 2000 Oct 10;16(15):1471-9.
  35. Ensoli F, Fiorelli V, Alario C, De Cristofaro M, Santini Muratori D, Novi A, Cunsolo MG, Mazzetta F, Giovannetti A, Mollicone B, Pinter E, Aiuti F. Decreased T cell apoptosis and T cell recovery during highly active antiretroviral therapy (HAART).Clin Immunol. 2000 Oct;97(1):9-20.
  36. Pierdominici M, Marziali M, Giovannetti A, Oliva A, Rosso R, Marino B, Digilio MC, Giannotti A, Novelli G, Dallapiccola B, Aiuti F, Pandolfi F.T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome.Clin Exp Immunol. 2000 Jul;121(1):127-32.
  37. Dianzani F, Antonelli G, Aiuti F, Turriziani O, Riva E, Capobianchi MR, Pandolfi F, D'Offizi G. The number of HIV DNA-infected mononuclear cells is reduced under HAART plus recombinant IL-2. IRHAN Study Group.Antiviral Res. 2000 Feb;45(2):95-9.
  38.  Rosso R, Mattiacci G, Bernardi ML, Guazzi V, Zaffiro A, Bellegrandi S, De Rocco MG, Bellioni-Businco B, Sirianni MC, Aiuti F, Paganelli R. Related Articles, Links Very delayed reactions to beta-lactam antibiotics. Contact Dermatitis. 2000 May;42(5):293-5.
  39. Carlesimo M, Bernardi ML, Mattiacci G, Pierdominici M, Ferrara R, Donnanno S, Alario C, Aiuti F. Evaluation of T-cell response to CD3 plus CD28 monoclonal antibodies in HIV-1 infected subjects treated with highly active antiretroviral therapy.J Biol Regul Homeost Agents. 2000 Jan-Mar;14(1):38-40.
  40. Giovannetti A, Pierdominici M, Mazzetta F, Mazzone AM, Ricci G, Prozzo A, Pandolfi F, Paganelli R, Aiuti F.HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease progression and apoptosis, but not with anti-CD3-induced T cell proliferation. AIDS Res Hum Retroviruses. 2000 Feb 10;16(3):211-9.
  41. Pandolfi F, Pierdominici M, Marziali M, Livia Bernardi M, Antonelli G, Galati V, D'Offizi G, Aiuti F. Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART. Clin Immunol. 2000 Mar;94(3):153-9.
  42. Mezzaroma I, Giovannetti A, Pinter E, Ensoli F, Aiuti F. Occurrence of Pneumocystis carinii pneumonia in HIV-1-infected patients responding to HAART: is prophylaxis discontinuation a safe tool?AIDS. 1999 Dec 3;13(17):2488-9.
  43. Isgro A, De Vita L, Mezzaroma I, Aiuti A, Aiuti F. Recovery of haematopoietic abnormalities in HIV-1 infected patients treated with HAART. AIDS. 1999 Dec 3;13(17):2486-8.
  44. Paganelli R, Mezzaroma I, Mazzone AM, Pinter E, Aiuti F. Leptin levels in HIV-positive patients treated with HAART. AIDS. 1999 Dec 3;13(17):2479.
  45. Mezzaroma I, Carlesimo M, Pinter E, Muratori DS, Di Sora F, Chiarotti F, Cunsolo MG, Sacco G, Aiuti F. Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy. Clin Infect Dis. 1999 Dec;29(6):1423-30.
  46. Giovannetti A, Ensoli F, Mazzetta F, De Cristofaro M, Pierdominici M, Muratori DS, Fiorelli V, Aiuti F. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.Clin Exp Immunol. 1999 Oct;118(1):87-94.
  47. Pontesilli O, Aiuti F.Immunisation with gp160 in HIV-1 infection.Lancet. 1999 Sep 11;354(9182):948-9.
  48. Froebel KS, Pakker NG, Aiuti F, Bofill M, Choremi-Papadopoulou H, Economidou J, Rabian C, Roos MT, Ryder LP, Miedema F, Raab GM.Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function. European Concerted Action on Immunological and Virological Markers of HIV Disease Progression. J Immunol Methods. 1999 Jul 30;227(1-2):85-97.
  49. Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristera R, Aiuti F, Ortona L, Ensoli B. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst. 1999 Sep 1;91(17):1468-74.
  50. Mezzaroma I, Carlesimo M, Pinter E, Alario C, Sacco G, Muratori DS, Bernardi ML, Paganelli R, Aiuti F. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS. 1999 Jul 9;13(10):1187-93.
  51. Zullo A, Romiti A, Rinaldi V, Vecchione A, Tomao S, Aiuti F, Frati L, Luzi G. Gastric pathology in patients with common variable immunodeficiency. Gut. 1999 Jul;45(1):77-81.
  52. Bellegrandi S, Rosso R, Mattiacci G, Ferrara R, D'Offizi G, Aiuti F, Mezzaroma I, Paganelli R. Contact dermatitis in subjects infected with HIV type 1.J Am Acad Dermatol. 1999 May;40(5 Pt 1):777-9.
  53. Ensoli F, Fiorelli V, DeCristofaro M, Santini Muratori D, Novi A, Vannelli B, Thiele CJ, Luzi G, Aiuti F.Inflammatory cytokines and HIV-1-associated neurodegeneration: oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons.J Immunol. 1999 May 15;162(10):6268-77.
  54. Bellegrandi S, Rosso R, Mattiacci G, Zaffiro A, Di Sora F, Menzella F, Aiuti F, Paganelli R. Combined immediate- and delayed-type hypersensitivity to metamizole. Allergy. 1999 Jan;54(1):88-90.
  55. Pierdominici M, Mollicone B, Ricci G, Oliva A, D'Offizi G, Giovannetti A, Aiuti F, Pandolfi F. Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): effects of administration of Zidovudine in vivo and interleukin-2 in vitro.Vaccine. 1998 Apr;16(7):715-21.
  56. Pontesilli O, Guerra EC, Ammassari A, Tomino C, Carlesimo M, Antinori A, Tamburrini E, Prozzo A, Seeber AC, Vella S, Ortona L, Aiuti F.Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. AIDS. 1998 Mar 26;12(5):473-80.
  57. Paganelli R, Scala E, Aiuti F, Fiorilli M. B-cell help by Tc2 cells. Immunol Today. 1998 Mar;19(3):142.
  58. Pandolfi F, Alario C, Girardi E, Rava L, Ippolito G, Kunkl A, Aiuti F. The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group. Clin Exp Immunol. 1998 Mar;111(3):564-73.
  59. Sirianni MC, Vincenzi L, Fiorelli V, Topino S, Scala E, Uccini S, Angeloni A, Faggioni A, Cerimele D, Cottoni F, Aiuti F, Ensoli B.Gamma-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages.Blood. 1998 Feb 1;91(3):968-76.
  60. Pivetti-Pezzi P, Accorinti M, Ciapparoni V, Vullo V, Aiuti F. Antiretroviral therapy and HIV-related retinal microangiopathy. AIDS. 1997 Dec;11(15):1890-1.
  61. Carlesimo M, Pontesilli O, Varani AR, Bernardi ML, Mazzone AM, Rosso R, Guerra EC, Cassone A, Paganelli R, Aiuti F. CD28 costimulation and T lymphocyte proliferative responses in HIV-1 infection. Clin Exp Immunol. 1997 Sep;109(3):406-11.
  62. Carlesimo M, Pontesilli O, Guerra EC, Varani AR, Bernardi ML, Ricci G, Alario C, Pirillo MF, Mattiacci G, Leone P, Cassone A, Aiuti F Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected persons.J Infect Dis. 1997 Oct;176(4):904-12.
  63. Romano A, Fanales-Belasio E, Di Fonso M, Giuffreda F, Palmieri V, Zeppilli P, Ansotegui IJ, Venuti A, Paganelli R, Aiuti F.Eosinophil-derived proteins in postprandial (food-dependent) exercise-induced anaphylaxis. Int Arch Allergy Immunol. 1997 Aug;113(4):505-11.
  64. Oliva A, Scala E, Quinti I, Paganelli R, Ansotegui IJ, Giovannetti A, Pierdominici M, Aiuti F, Pandolfi F. IL-10 production and CD40L expression in patients with common variable immunodeficiency. Scand J Immunol. 1997 Jul;46(1):86-90.
  65. Scala E, D'Offizi G, Rosso R, Turriziani O, Ferrara R, Mazzone AM, Antonelli G, Aiuti F, Paganelli R. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J Immunol. 1997 May 1;158(9):4485-92.
  66. D'Arminio Monforte A, Musicco M, Galli M, Paga C, La Regina A, Lazzarin A, Angarano G, Milazzo F, Gritti F, Arlotti M, Mazzotta F, Visco G, Aiuti F, Moroni M. Italian multicentre study of didanosine compassionate use in advanced HIV infection. Italian BMS-906 Study Group. Eur J Clin Microbiol Infect Dis. 1997 Feb;16(2):135-42.
  67. Giovannetti A, Quinti I, Rainaldi L, Mauro FR, Oliva A, Pierdominici M, Ricci G, De Rossi G, Cassone A, Aiuti F, Pandolfi F.Proliferative responses to PHA, anti-CD3 and antigens in patients with lymphoproliferative disease of granular lymphocytes. Mannoproteins of Candida albicans induce proliferation and cytotoxicity. Acta Haematol. 1997;98(2):65-71.
  68. Paganelli R, Scala E, Mazzone AM, Rosso R, Mattiacci G, Dell'Anna L, Mezzaroma I, Aiuti F. Th2-type cytokines, hypereosinophilia, and interleukin-5 in HIV disease.Allergy. 1997 Jan;52(1):110-1. Review.
  69. Quinti I, Giovannetti A, Paganelli R, Pucillo LP, Varani AR, Ricci G, Scala E, Pandolfi F, Casato M, Aiuti F. HCV infection in a patient with hyper IgM syndrome.J Clin Immunol. 1996 Nov;16(6):321-5.
  70. Dondero F, Rossi T, D'Offizi G, Mazzilli F, Rosso R, Sarandrea N, Pinter E, Aiuti F. Semen analysis in HIV seropositive men and in subjects at high risk for HIV infection. Hum Reprod. 1996 Apr;11(4):765-8.
  71. Quinti I, Pandolfi F, Paganelli R, Giovannetti A, Sacco G, Oliva A, Aiuti F. Hepatitis C virus infection in Italian patients with hypogammaglobulinemia.Clin Ther. 1996;18 Suppl B:96-107.
  72. Guerra E, Ricci G, Carlesimo M, Varani AR, Pontesilli O, Scala E, Mezzaroma I, Pierdominici, Pandolfi F, Antinori A, De Luca A, Murri R, Ammassari A, Ortona L, Aiuti F. Immunological aspects of patients with HIV-1 disease following immunization with recombinant gp160 (VaxSyn). Antibiot Chemother. 1996;48:147-54.
  73. Scala E, Ansotegui IJ, Bellioni B, Guerra EC, Aiuti F, Paganelli R. Expansion of CD11abright cells in CD8+CD45RA+ from HIV-infected patients: a new early marker for disease progression? AIDS Res Hum Retroviruses. 1995 Nov;11(11):1327-33.
  74. Nigro G, Luzi G, Krzysztofiak A, D'Orio F, Aiuti F. Detection of IgM antibodies to human herpesvirus 6 in Romanian children with nonprogressive human immunodeficiency virus disease.Pediatr Infect Dis J. 1995 Oct;14(10):891-4.
  75. Quinti I, Pandolfi F, Paganelli R, el Salman D, Giovannetti A, Rosso R, Oliva A, Rainaldi L, Aiuti F. HCV infection in patients with primary defects of immunoglobulin production. Clin Exp Immunol. 1995 Oct;102(1):11-6.
  76. Rezza G, Pezzotti P, Aiuti F. Acquired immunodeficiency without HIV infection: epidemiology and clinical outcome in Italy. The Italian Study Group on non-HIV AIDS.BMJ. 1995 Sep 23;311(7008):785-6.
  77. Oliva A, Quinti I, Scala E, Fanales-Belasio E, Rainaldi L, Pierdominici M, Giovannetti A, Paganelli R, Aiuti F, Pandolfi F.Immunodeficiency with hyperimmunoglobulinemia M in two female patients is not associated with abnormalities of CD40 or CD40 ligand expression. J Allergy Clin Immunol. 1995 Sep;96(3):403-10.
  78. Pandolfi F, Pierdominici M, Oliva A, D'Offizi G, Mezzaroma I, Mollicone B, Giovannetti A, Rainaldi L, Quinti I, Aiuti F. Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression.J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 15;9(5):450-8.
  79. Aiuti F, D'Offizi G.Immunologic and virologic studies in long-term non-progressor HIV infected individuals. NOPHROCO Study Group. Non progressors HIV + Roman cohort.J Biol Regul Homeost Agents. 1995 Jul-Sep;9(3):82-7.
  80. Pontesilli O, Carlesimo M, Varani AR, Ferrara R, Guerra EC, Bernardi ML, Ricci G, Mazzone AM, D'Offizi G, Aiuti F. HIV-specific lymphoproliferative responses in asymptomatic HIV-infected individuals. Clin Exp Immunol. 1995 Jun;100(3):419-24.
  81. Scala E, Bellioni B, Guerra EC, Aiuti F, Paganelli R. CD8+CD45RA+ in HIV-infected patients are predominantly CD11abright.AIDS. 1995 Jun;9(6):653-4.
  82. Paganelli R, Scala E, Mezzaroma I, Pinter E, D'Offizi G, Fanales-Belasio E, Rosso RM, Ansotegui IJ, Pandolfi F, Aiuti F. Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS. J Allergy Clin Immunol. 1995 May;95(5 Pt 1):995-1003.
  83. Giovannetti A, Aiuti A, Pizzoli PM, Pierdominici M, Agostini E, Oliva A, Dianzani F, Aiuti F, Pandolfi F. Tyrosine phosphorylation pathway is involved in interferon-gamma (IFN-gamma) production; effect of sodium ortho vanadate.Clin Exp Immunol. 1995 Apr;100(1):157-63.
  84. Carotenuto P, Quinti I, Pontesilli O, Hall AJ, DeLange GG, Whittle HC, D'Amelio R, Aiuti F. Response to hepatitis B vaccine in a cohort of Gambian children.Pediatr Infect Dis J. 1995 Mar;14(3):215-20.
  85. Taliani G, Guerra E, Rosso R, Badolato MC, Luzi G, Sacco G, Lecce R, De Bac C, Aiuti F. Hepatitis C virus infection in hypogammaglobulinemic patients receiving long-term replacement therapy with intravenous immunoglobulin.Transfusion. 1995 Feb;35(2):103-7.
  86. Sirianni MC, Mezzaroma I, Aiuti F, Moretta A. Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody.Eur J Immunol. 1994 Aug;24(8):1874-8.
  87. Sirianni MC, Ansotegui IJ, Aiuti F, Wigzell H. Natural killer cell stimulatory factor (NKSF)/IL-12 and cytolytic activities of PBL/NK cells from human immunodeficiency virus type-1 infected patients. Scand J Immunol. 1994 Jul;40(1):83-6.
  88. Quinti I, Sacco G, el Salman D, Paganelli R, Fiorilli M, Aiuti F, Pandolfi F. Infection with hepatitis C virus. Intravenous gammaglobulin may still infect patients.BMJ. 1994 Mar 26;308(6932):856.
  89. Aiuti F. Impediments to Italian science.Nature. 1994 Feb 17;367(6464):590.
  90. Pontesilli O, Carlesimo M, Varani AR, Ferrara R, D'Offizi G, Aiuti F. In vitro lymphocyte proliferative response to HIV-1 p24 is associated with a lack of CD4+ cell decline. AIDS Res Hum Retroviruses. 1994 Feb;10(2):113-4.
  91. Pivetti-Pezzi P, Tamburi S, Accorinti M, Mezzaroma I, Vullo V, Sorice F, Aiuti F. Immunological and viral markers of HIV infection and retinal microangiopathy.Eur J Ophthalmol. 1993 Jul-Sep;3(3):138-42.
  92. Cassone A, Palma C, Djeu JY, Aiuti F, Quinti I. Anticandidal activity and interleukin-1 beta and interleukin-6 production by polymorphonuclear leukocytes are preserved in subjects with AIDS.J Clin Microbiol. 1993 May;31(5):1354-7.
  93. Pandolfi F, Paganelli R, Oliva A, Quinti I, Polidori V, Fanales-Belasio E, Guerra E, Aiuti F. Increased IL-6 gene expression and production in patients with common variable immunodeficiency. Clin Exp Immunol. 1993 May;92(2):239-44.
  94. Dell'Anna L, Carbonari M, Cibati M, Aiuti F, Fiorilli M. Insoluble gp120/anti-gp120 antibody complexes enhance T-cell activation. AIDS. 1993 May;7(5):739-40.
  95. Pandolfi F, Oliva A, Sacco G, Polidori V, Liberatore D, Mezzaroma I, Giovannetti A, Kurnick JT, Aiuti F. Fibroblast-derived factors preserve viability in vitro of mononuclear cells isolated from subjects with HIV-1 infection. AIDS. 1993 Mar;7(3):323-9.
  96. Aiuti F, Ensoli F, Fiorelli V, Mezzaroma I, Pinter E, Guerra E, Varani AR. Vaccine. 1993;11(5):538-41.
  97. Solano L, Costa M, Salvati S, Coda R, Aiuti F, Mezzaroma I, Bertini M. Psychosocial factors and clinical evolution in HIV-1 infection: a longitudinal study.J Psychosom Res. 1993 Jan;37(1):39-51.
  98. Sirianni MC, Pandolfi F, Verani P, Guerra E, Rossi GB, Aiuti F. CD4 defect without HIV in patients with opportunistic infections or Kaposi's sarcoma.AIDS. 1993 Jan;7(1):130-1.
  99. Pandolfi F, Paganelli R, Cafaro A, Oliva A, Giovannetti A, Scala E, Quinti I, Aiuti F. Abnormalities of lymphocyte subpopulations in CVI do not correlate with increased production of IL-6. Immunodeficiency. 1993;4(1-4):19-23.
  100. Paganelli R, Scala E, Ansotegui IJ, Mezzaroma I, Pinter E, Ferrara R, D'Offizi GP, Aiuti F. Hyper IgE syndrome induced by HIV infection.Immunodeficiency. 1993;4(1-4):149-52.
  101. Paganelli R, Scala E, Scarselli E, Ortolani C, Cossarizza A, Carmini D, Aiuti F, Fiorilli M. Selective deficiency of CD4+/CD45RA+ lymphocytes in patients with ataxia-telangiectasia.J Clin Immunol. 1992 Mar;12(2):84-91.
  102. Chen H, Pesce AM, Carbonari M, Ensoli F, Cherchi M, Campitelli G, Sbarigia D, Luzi G, Aiuti F, Fiorilli M. Absence of antibodies to human herpesvirus-6 in patients with slowly-progressive human immunodeficiency virus type -1 infection. Eur. J. Epidemiol. 1992 Mar;8(2):217-21.

Libri ed enciclopedie:

  • F. Aiuti e C. Gallucci: Nessuna Condanna - Sperling e Kupfer Ed. 1993 
  • F. Aiuti: "Sapere uguale vivere", a cura dell'ANLAIDS.
    Libro di informazione sull'AIDS per i giovani, per gli adulti, per la scuola e per la famiglia.
  • I Linfociti: Enciclopedia del Novecento
    Enciclopedia Italiana del Novecento Fondata da Treccani. Ed. 1989 e successivi aggiornamenti.
  • Primary Immunodeficiencies Diseases, Ed. Bergsma 1993.
  • Le Immunodeficienze primitive: Trattato di Patologia Medica (Rasario)